Suppressive effects of furonaphthoquinone NFD-37 on the production of lipopolysaccharide-inducible inflammatory mediators in macrophages RAW 264.7

被引:5
作者
Kim, MH
Shin, HM
Lee, YR
Chung, EY
Chang, YS
Min, KR
Kim, Y [1 ]
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[2] Chungbuk Natl Univ, Res Ctr Bioresource & Hlth, Cheongju 361763, South Korea
[3] Yeungnam Univ, Sch Chem Engn & Technol, Kyongsan 712749, South Korea
关键词
furonaphthoquinone; NO; PGE(2); cytokine; anti-inflammation;
D O I
10.1007/BF02972982
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
2-Methyl-2-(2-methylpropenyl)-2,3-dihydronaphthoquinone[2,3-b]furan-4,9-dione (NFD-37) is a synthetic furonaphthoquinone compound. In this study, we determined that NFD-37 could inhibit the lipopolysaccharide (LPS)-induced production of inflammatory mediators in macrophages RAW 264.7. This compound inhibited LPS-induced nitric oxide (NO) or prostaglandin (PG) E-2 production in dose-dependent manners, with IC50 values of 7.2 mu M and 5.3 mu M, respectively. As the positive controls, pyrrolidine dithiocarbamate (30 M) exhibited a 57% inhibition of NO production, and NS-398 (1 mu M) manifested a 48% inhibition of PGE(2) production. The inhibitory effects of NFD-37 on NO and PGE2 production were determined to occur in conjunction with the suppression of inducible NO synthase or cyclooxygenase-2 expression. NFD-37 also inhibited the production of LPS-inducible tumor necrosis factor-a, interleukin (IL)-1 beta and IL-6, at IC50 values of 4.8-8.9 mu M. We also determined the anti-inflammatory efficacy of NFD-37 using carrageenin-induced paw edema in experimental mice.
引用
收藏
页码:1170 / 1176
页数:7
相关论文
共 23 条
[1]
Prostaglandins in the stomach: An update [J].
Arakawa, T ;
Higuchi, K ;
Fukuda, T ;
Fujiwara, Y ;
Kobayashi, K ;
Kuroki, T .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 27 :S1-S11
[2]
Current approaches to prevent NSAID-induced gastropathy - COX selectivity and beyond [J].
Becker, JC ;
Domschke, W ;
Pohle, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (06) :587-600
[3]
Bovill JG, 2003, ADV EXP MED BIOL, V523, P201
[4]
Anti-inflammatory agents and renal function [J].
Brater, DC .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2002, 32 (03) :33-42
[5]
CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 EXPRESSION IN RHEUMATOID SYNOVIAL TISSUES - EFFECTS OF INTERLEUKIN-1-BETA, PHORBOL ESTER, AND CORTICOSTEROIDS [J].
CROFFORD, LJ ;
WILDER, RL ;
RISTIMAKI, AP ;
SANO, H ;
REMMERS, EF ;
EPPS, HR ;
HLA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1095-1101
[6]
LPS induction of gene expression in human monocytes [J].
Guha, M ;
Mackman, N .
CELLULAR SIGNALLING, 2001, 13 (02) :85-94
[7]
Hopkins Stephen John, 2003, Leg Med (Tokyo), V5 Suppl 1, pS45, DOI 10.1016/S1344-6223(02)00088-3
[8]
Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503
[9]
Inoue H, 1997, ADV EXP MED BIOL, V407, P139
[10]
Induction of inflammatory cytokines and nitric oxide in J774.2 cells and murine macrophages by lipoteichoic acid and related cell wall antigens from Staphylococcus epidermidis [J].
Jones, KJ ;
Perris, AD ;
Vernallis, AB ;
Worthington, T ;
Lambert, PA ;
Elliott, TSJ .
JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (04) :315-321